Ninety-day Local Tolerability and Toxicity Study of ND0612, a Novel Formulation of Levodopa/Carbidopa, Administered by Subcutaneous Continuous Infusion in Minipigs.

MLA

Ramot, Yuval, et al. “Ninety-Day Local Tolerability and Toxicity Study of ND0612, a Novel Formulation of Levodopa/Carbidopa, Administered by Subcutaneous Continuous Infusion in Minipigs.” Toxicologic Pathology, vol. 45, no. 6, Aug. 2017, pp. 764–73. EBSCOhost, https://doi.org/10.1177/0192623317729891.

APA

Ramot, Y., Nyska, A., Maronpot, R. R., Shaltiel-Karyo, R., Tsarfati, Y., Manno, R. A., Sacco, G., & Yacoby-Zeevi, O. (2017). Ninety-day Local Tolerability and Toxicity Study of ND0612, a Novel Formulation of Levodopa/Carbidopa, Administered by Subcutaneous Continuous Infusion in Minipigs. Toxicologic Pathology, 45(6), 764–773. https://doi.org/10.1177/0192623317729891

Chicago

Ramot, Yuval, Abraham Nyska, Robert R Maronpot, Ronit Shaltiel-Karyo, Yonit Tsarfati, Rosa Anna Manno, Giuseppe Sacco, and Oron Yacoby-Zeevi. 2017. “Ninety-Day Local Tolerability and Toxicity Study of ND0612, a Novel Formulation of Levodopa/Carbidopa, Administered by Subcutaneous Continuous Infusion in Minipigs.” Toxicologic Pathology 45 (6): 764–73. doi:10.1177/0192623317729891.